NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 2nd. Investors of record on Thursday, January 23rd will be paid a dividend of $0.50 per share on Monday, February 3rd. This represents a $2.00 annualized dividend and a yield of 2.80%. The ex-dividend date of this dividend is Wednesday, January 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings results on Wednesday, February, 12th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.68 by $0.05. The pharmacy operator had revenue of $66.89 billion for the quarter, compared to analysts' expectations of $64.01 billion. CVS Health had a return on equity of 14.87% and a net margin of 2.58%. CVS Health's quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.14 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY20 earnings guidance on Wednesday, February, 12th. The company provided earnings per share (EPS) guidance of $7.04-7.17 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.15.

25 equities research analysts have issued 12 month target prices for CVS Health's shares. Their forecasts range from $61.00 to $109.00. On average, they expect CVS Health's share price to reach $79.77 in the next twelve months. This suggests a possible upside of 11.6% from the stock's current price. View Analyst Price Targets for CVS Health.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 6 hold ratings, 17 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media coverage about CVS stock has been trending extremely negative recently, according to InfoTrie. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CVS Health earned a news sentiment score of -4.2 on InfoTrie's scale. They also assigned media headlines about the pharmacy operator a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Verizon Communications (VZ), Johnson & Johnson (JNJ), QUALCOMM (QCOM) and Intel (INTC).

CVS Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Wealth Quarterback LLC (9.74%), State Street Corp (4.29%), FMR LLC (2.17%), Capital International Investors (1.90%), Geode Capital Management LLC (1.43%) and Franklin Resources Inc. (1.38%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, State Street Corp, Franklin Resources Inc., FMR LLC, Marshall Wace North America L.P., Caisse DE Depot ET Placement DU Quebec, FIL Ltd and Boston Partners. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Capital World Investors, LSV Asset Management, M&G Investment Management Ltd., PNC Financial Services Group Inc., Lord Abbett & CO. LLC, Janus Henderson Group PLC and Amundi Pioneer Asset Management Inc.. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $71.47.

CVS Health has a market capitalization of $93.21 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]